Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 7/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.52 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.52 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | KIT | P10721 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14478662 | 0.90 | PDGFRB (0.45) | CYP11B1CYP11B2CYP19A1CYP17A1KDM4E | |
| SCHEMBL14478617 | 0.85 | MAPK9 (0.40) | CYP11B1CYP11B2CYP19A1CYP17A1KDM4E | |
| SCHEMBL14478673 | 0.83 | ADORA2A (0.40) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL14478665 | 0.82 | TDP2 (0.41) | CYP11B1CYP11B2CYP17A1CYP2A6NPC1 | |
| SCHEMBL14478694 | 0.81 | ALDH1A1 (0.42) | CYP11B1CYP11B2CYP19A1CYP17A1NPC1 | |
| SCHEMBL13642938 | 0.80 | CYP11B1 (0.61) | CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL13084029 | 0.79 | CYP11B1 (0.60) | CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL13083988 | 0.79 | CYP11B1 (0.60) | CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL14478693 | 0.79 | DHFR (0.39) | CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6 | |
| SCHEMBL19168348 | 0.79 | CYP11B1 (0.57) | CYP11B1CYP11B2CYP19A1CYP17A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8986855-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-03-24 | — | — | US | disclosed |
| US-8986855-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-03-24 | — | — | US | disclosed |
| US-8951649-B2 | — | — | 2015-02-10 | — | — | US | disclosed |
| US-8951649-B2 | — | — | 2015-02-10 | — | — | US | disclosed |
| US-20130001529-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-01-03 | — | — | US | disclosed |
| US-20130001529-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130001529-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, ORC3, NR2E3 | CYP11B1 796/4885CYP11B2 880/4885CYP19A1 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.